Over a 2015-year period, Richard has served as statistician on over 50 70 IDMCs/DSMBs. These have covered phase I, phase II and phase III clinical trials in a variety of therapeutic areas. including Oncology, MS, Urology, COPD, Diabetes, Coronavirus, Dermatitis, Psoriasis, Ulcerative Colitis and HIV. He has also become involved in advising companies on the set-up and functioning of such committees. Richard has served as a member of several Steering Committees and Advisory Boards for individual trials and collections of trial programmes.